• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

TempoPay Launches Rx Financing Solution to Combat Prescription Non-Adherence Due to Cost

by Fred Pennic 04/30/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
TempoPay Launches Rx Financing Solution to Combat Prescription Non-Adherence Due to Cost

What You Should Know: 

– TempoPay, a subsidiary of healthcare financing provider PayMedix announced the launch of TempoPay Rx, a new financing solution specifically designed to help individuals afford prescription medications and address the growing problem of non-adherence driven by cost.

– The launch of TempoPay Rx is also positioned as a strategy to lower overall healthcare expenditures. Medication non-adherence is known to lead to worsening health conditions, resulting in increased emergency room visits and hospital admissions, which drive up costs for employers and the healthcare system.

Addressing the Crisis of Prescription Affordability

Access and affordability of prescription drugs have become critical concerns as prices rise at more than double the rate of inflation. Nearly two-thirds (61%) of Americans take prescription medications, and over half (55%) worry about affording them. This financial strain leads to serious health consequences, with nearly one-third (31%) reporting they have avoided taking medications as prescribed specifically due to cost concerns.

How TempoPay Rx Works

TempoPay Rx offers a card-based solution providing enrolled employees and their dependents access to interest-free financing for their prescription medications. Key features include:

  • Interest-Free Financing: Funds are provided on a revolving basis with no interest or fees.
  • Easy Access: Members can pay using a TempoPay VISA® card or their mobile wallet via the TempoPay app.
  • No Barriers to Enrollment: Employees of participating employers can receive the benefit without credit checks or income requirements.

Flexible Repayment: Terms allow for repayment via bank account or convenient payroll deductions.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |